Marmoset cytochrome P450 2J2 mainly expressed in small intestines and livers effectively metabolizes human P450 2J2 probe substrates, astemizole and terfenadine

References

• Bieche I, Narjoz C, Asselah T, et al. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genom 17:731–42.
   PubMed Web of Science ®Google Scholar
• Campbell WB, Fleming I. (2010). Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Arch 459:881–95.
   PubMed Web of Science ®Google Scholar
• Dutheil F, Dauchy S, Diry M, et al. (2009). Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos 37:1528–38.
   PubMed Web of Science ®Google Scholar
• Evangelista EA, Kaspera R, Mokadam NA, et al. (2013). Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes. Drug Metab Dispos 41:2087–94.
   PubMed Web of Science ®Google Scholar
• Feng W, Xu X, Zhao G, et al. (2013). EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells. – apoptosis pulmonary endothelial and – migration pulmonary smooth cells. Int J Mol Med 32:685–93.
   PubMed Web of Science ®Google Scholar
• Fleming I. (2001). Cytochrome p450 and vascular homeostasis. Circ Res 89:753–62.
   PubMed Web of Science ®Google Scholar
• Graves JP, Edin ML, Bradbury JA, et al. (2013). Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily. Drug Metab Dispos 41:763–73.
   PubMed Web of Science ®Google Scholar
• Hashizume T, Imaoka S, Mise M, et al. (2002). Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300:298–304.
   PubMed Web of Science ®Google Scholar
• Hashizume T, Mise M, Matsumoto S, et al. (2001). A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine. Drug Metab Dispos 29:798–805.
   PubMed Web of Science ®Google Scholar
• Iliff JJ, Wang R, Zeldin DC, Alkayed NJ. (2009). Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels. Am J Physiol Heart Circ Physiol 296:H1352–63.
   PubMed Web of Science ®Google Scholar
• Imig JD. (2005). Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol 289:F496–503.
   PubMed Web of Science ®Google Scholar
• Jagessar SA, Vierboom M, Blezer EL, et al. (2013). Overview of models, methods, and reagents developed for translational autoimmunity research in the common marmoset (Callithrix jacchus). Exp Anim 62:159–71.
   PubMed Web of Science ®Google Scholar
• Kikuta Y, Sogawa K, Haniu M, et al. (1991). A novel species of cytochrome P-450 (P-450ib) specific for the small intestine of rabbits. cDNA cloning and its expression in COS cells. J Biol Chem 266:17821–5.
   PubMed Web of Science ®Google Scholar
• Lee AC, Murray M. (2010). Up-regulation of human CYP2J2 in HepG2 cells by butylated hydroxyanisole is mediated by c-Jun and Nrf2. Mol Pharmacol 77:987–94.
   PubMed Web of Science ®Google Scholar
• Lee CA, Neul D, Clouser-Roche A, et al. (2010). Identification of novel substrates for human cytochrome P450 2J2. Drug Metab Dispos 38:347–56.
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Hirama T, Matsubara T, et al. (2002). Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole. Drug Metab Dispos 30:1240–5.
   PubMed Web of Science ®Google Scholar
• Messina A, Siniscalco A, Puccinelli E, et al. (2012). Cloning and tissues expression of the pig CYP1B1 and CYP2J34. Res Vet Sci 92:438–43.
   PubMed Web of Science ®Google Scholar
• Nishimuta H, Sato K, Mizuki Y, et al. (2011). Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans. Drug Metab Pharmacokinet 26:300–6.
   PubMed Web of Science ®Google Scholar
• Okano H, Hikishima K, Iriki A, Sasaki E. (2012). The common marmoset as a novel animal model system for biomedical and neuroscience research applications. Semin Fetal Neonatal Med 17:336–40.
   PubMed Web of Science ®Google Scholar
• Omatsu T, Moi ML, Hirayama T, et al. (2011). Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 92:2272–80.
   PubMed Web of Science ®Google Scholar
• Orsi A, Rees D, Andreini I, et al. (2011). Overview of the marmoset as a model in nonclinical development of pharmaceutical products. Regul Toxicol Pharmacol 59:19–27.
   PubMed Web of Science ®Google Scholar
• Qu W, Bradbury JA, Tsao CC, et al. (2001). Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain. J Biol Chem 276:25467–79.
   PubMed Web of Science ®Google Scholar
• Sasaki E, Suemizu H, Shimada A, et al. (2009). Generation of transgenic non-human primates with germline transmission. Nature 459:523–7.
   PubMed Web of Science ®Google Scholar
• Scarborough PE, Ma J, Qu W, Zeldin DC. (1999). P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab Rev 31:205–34.
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–23.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Iwano S, Uno Y, et al. (2014). Qualitative de novo analysis of full length cDNA and quantitative analysis of gene expression for common marmoset (Callithrix jacchus) transcriptomes using parallel long-read technology and short-read sequencing. PLoS One 9:e100936
   PubMed Web of Science ®Google Scholar
• Spector AA, Norris AW. (2007). Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol 292:C996–1012.
   PubMed Web of Science ®Google Scholar
• Tardif S, Ross C, Bergman P, et al. (2015). Testing efficacy of administration of the antiaging drug rapamycin in a nonhuman primate, the common marmoset. J Gerontol Biol Sci Med Sci 70:577–87.
   PubMed Web of Science ®Google Scholar
• Tardif SD, Mansfield KG, Ratnam R, et al. (2011). The marmoset as a model of aging and age-related diseases. ILAR J 52:54–65.
   PubMed Web of Science ®Google Scholar
• Uehara S, Murayama N, Nakanishi Y, et al. (2011). Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys. J Pharmacol Exp Ther 339:654–61.
   PubMed Web of Science ®Google Scholar
• Uehara S, Murayama N, Nakanishi Y, et al. (2014). Immunochemical detection of cytochrome P450 enzymes in small intestine microsomes of male and female untreated juvenile cynomolgus monkeys. Xenobiotica 44:769–74.
   PubMed Web of Science ®Google Scholar
• Uehara S, Murayama N, Nakanishi Y, et al. (2015a). Immunochemical quantification of cynomolgus CYP2J2, CYP4A and CYP4F enzymes in liver and small intestine. Xenobiotica 45:124–30.
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Hagihira Y, et al. (2015b). Marmoset cytochrome P450 2D8 in livers and small intestines metabolizes typical human P450 2D6 substrates, metoprolol, bufuralol and dextromethorphan. Xenobiotica 45:766–72.
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, et al. (2015c). Novel marmoset cytochrome P450 2C19 in livers efficiently metabolizes human P450 2C9 and 2C19 substrates, S-warfarin, tolbutamide, flurbiprofen, and omeprazole. Drug Metab Dispos 43:1408–16.
   PubMed Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, et al. (2015d). Substrate selectivities and catalytic activities of marmoset liver cytochrome P450 2A6 differed from those of human P450 2A6. Drug Metab Dispos 43:969–76.
   PubMed Web of Science ®Google Scholar
• Uehara S, Inoue T, Utoh M, et al. (2016a). Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol and midazolam, in common marmosets (Callithrix jacchus). Xenobiotica 43:163–8.
   Web of Science ®Google Scholar
• Uehara S, Uno Y, Inoue T, et al. (2016b). Molecular cloning, tissue distribution, and functional characterization of marmoset cytochrome P450 1A1, 1A2, and 1B1. Drug Metab Dispos 44:8–15.
   PubMed Web of Science ®Google Scholar
• Uno Y, Hosaka S, Matsuno K, et al. (2007). Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism? Arch Biochem Biophys 466:98–105.
   PubMed Web of Science ®Google Scholar
• Wang X, Ni L, Yang L, et al. (2014). CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure. Mol Pharmacol 85:105–15.
   PubMed Web of Science ®Google Scholar
• Wu S, Chen W, Murphy E, et al. (1997). Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272:12551–9.
   PubMed Web of Science ®Google Scholar
• Wu S, Moomaw CR, Tomer KB, et al. (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460–8.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakamura M, Komatsu T, et al. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329–37.
   PubMed Web of Science ®Google Scholar
• Zhang QY, Ding X, Kaminsky LS. (1997). CDNA cloning, heterologous expression, and characterization of rat intestinal CYP2J4. Arch Biochem Biophys 340:270–8.
   PubMed Web of Science ®Google Scholar